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Introduction
Anesthesiology is one of the few major medical specialties where discoveries are 
clearly documented, by the introduction of general anesthesia, and local anesthesia 
(1,2). The last century has witnessed many developments in the practice of regional 
anesthesia. What began as a simple method of numbing body parts of the body during 
surgery has expanded to creating a neural blockade during the perioperative period, 
either as the sole anesthetic or in combination with general anesthesia. Local anesthetic 
agents are also increasingly being used in the treatment of chronic pain syndromes. 
Techniques have evolved from topical application and local infiltration to selective 
blockade of nerves and plexuses, neuraxial blocks, and the use of ultrasonography 
to identify neural structures. The purpose of this review is to offer a comprehensive 
curriculum in HORA (history of regional anesthesia) that could be implemented in 
training programs.
During a brief online survey conducted regarding the teaching of regional anesthesia 
in acute pain programs across the country we realized that much needed to be done in 
that matter.
Some of the barriers identified were lack of trained faculty in the topic, time 
constrains and most of all the absence of a curriculum to teach HORA. Even the latest 
guidelines for fellowship training in regional anesthesiology and acute pain medicine 
published by ASRA in 2015 did not include a curriculum to teach HORA.
Discussion and Proposed HORA Curriculum
This review of the history of regional anesthesia puts forward the following topics 
as recommendations to be included in the core curriculum for the teaching of HORA: the 
emergence of ASRA; local anesthetic agents; spinal and epidural anesthesia; brachial 
plexus block; ultrasonography and the recognition that regional anesthesia reduces 
morbidity and shorter recovery room stays when compared with general anesthesia in 
ambulatory surgery.
 The origin of American Society of Regional Anesthesia and Pain Medicine (ASRA)
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Abstract
The study of the past with regards to medical history has been an underemphasized 
component of the medical school curriculum for several reasons.
These have included the lack of direct or immediate clinical impact, the emergence of 
new disciplines such as medical ethics, expansion of the existing knowledge base, as well 
as a lack of research grants and funding. The curriculum in graduate medical education 
struggles to cope with the explosion of new information related to basic and applied 
sciences. The elimination of questions related to history in certifying examinations could be 
considered a fatal blow. This study explored the teaching of history of regional anesthesia 
(HORA) and proposes a curriculum for such education.
A formal curriculum has not been described in published literature, even the latest 
guidelines for fellowship training in regional anesthesiology and acute pain medicine 
published by ASRA in 2015 did not include a curriculum to teach HORA. We propose a 
curriculum related to a variety of topics that would provide useful information and enrich 
the educational experience of trainees. It is suggested that this briefly formatted review of 
HORA could be used as a starting point for teaching and research to place major events of 
this specialty in an historical context.
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The original ASRA was founded in 1923. It was created to 
honor Gaston Labat, who has been called the “father” of regional 
anesthesia and pain medicine in the United States. Labat was a 
French surgeon and came to America with Mayo Clinic founder 
Charles Mayo. Labat worked in several hospitals in the U.S. 
and created a course in regional anesthesia through New York 
University at Bellevue Hospital. The original ASRA grew out 
of this work with a focus on the development of local, 
regional, and spinal anesthesia. 
In 1930, Philip Woodbridge presented at an ASRA meeting on 
the use of therapeutic blocks for chronic pain, which signified a 
shift in focus to also include pain management in the Society’s 
purview. The association was no longer focused solely on surgical 
anesthesia, with pain management becoming increasingly 
emphasized in papers and meetings [3].
Despite numerous advances in regional anesthesia and pain 
medicine throughout the 1930s, ASRA as an organization began 
to lose steam by the end of the decade. Meetings were held less 
frequently, and fewer members were paying their dues. In 1940, 
the group was dissolved, and members were invited to join the 
American Society of Anesthesiology, which had been established 
early in the 20th century.
In 1973 Alon Winnie had a vision of an organization that 
would be devoted to teaching regional anesthesia. He shared his 
vision with Harold Carron, Jordan Katz, Donald Bridenbaugh, 
and P. Prithvi Raj, who reestablished the society in 1975 [4]. 
Interestingly, the reinvented ASRA originally focused on regional 
anesthesia but later added pain medicine in the 1990s. 
At the time of the society’s first meeting on March 18, 1978, 
the society had more than 300 members. Today it has more 
than 6500 physician and scientist members and the journal 
Regional Anesthesia and Pain Medicine, is read by over 9000 
subscribers internationally.
Today, ASRA is one of the largest subspecialty medical 
societies in anesthesiology. Change is constant in the field of 
regional anesthesia and pain medicine as new discoveries are 
made, changes occur in healthcare administration and insurance, 
and demographic shifts occur in the patient population. Although 
many organizations and companies provide offerings to address 
the needs of individuals working with these challenges, ASRA 
remains committed to a focus on the highest quality of evidence-
based education and research for physicians. This history of 
ASRA is relevant to today’s anesthesiologist so we don’t forget 
the heritage of the past to make certain that regional anesthesia 
is always available to the patients for whom we care.
Local Anesthetics:
Cocaine: Extracts from the coca plant have been consumed by 
natives of the Andes region in South America for over 5000 years 
[3,4]. The active ingredient was separated from the leaves 
using lime, and used as a stimulant , to decrease air hunger, and 
to increase endurance. The Incas were the first to observe local 
anesthetic properties of saliva rich with coca extract. 
Centuries later, modern chemical processes allowed the 
extraction, purification, and identification of cocaine. Richard 
Willstatter [1872-1942] elucidated the structure of plant 
alkaloids such as atropine and cocaine as part of his doctoral 
thesis, and later also explored the structure of chlorophyll. 
For his many contributions to the understanding of plant 
chemistry,he was awarded the Nobel Prize in Chemistry in 
1915 [5,6]. Cocaine’s most notable advocate at that time was 
Sigmund Freud [1856-1939], the famous psychoanalyst, who 
believed it could be used to cure depression, as well as addiction 
to morphine or alcohol. He self-experimented with cocaine and 
described many of its properties but failed to notice its local 
anesthetic properties [7,8]. That distinction went to Freud’s 
colleague, a rising ophthalmologist Carl Koller [1857- 1944], who 
observed the tongue-numbing properties of the drug and his 
team continued with self-experimentation feeling no pain as they 
touched their own eyes with needles. In 1884 his work debuted 
at the German Ophthalmological Society Conference in 
Heidelberg and the international medical community quickly 
learned about the local anesthetic properties of cocaine [9].
As with the discovery of general anesthesia, controversy arose 
about the individual[s] who deserved credit for the discovery 
of the local anesthetic properties of cocaine. Two other 
'practitioners', Vassily von Anrep [1852-1927] and Theodor 
Aschenbrandt claimed to have discovered these properties 
before Koller’s 1884 presentation, but pressure from the 
medical community in Vienna caused them to reliquish their 
claims and acknowledge Koller’s contribution [10,11]. Later, 
other physicians used cocaine to obtain analgesia during 
surgery. William Halsted [1852-1922] used cocaine for a 
mandibular nerve block during dental surgery [12] and also for 
a brachial plexus block [13], while August Bier [1861-1949] 
used it intrathecally as an anesthetic [14]. Self-experimentation 
resulted in many physicians, including Freud and Halsted, 
becoming dependent on drugs such as morphine and cocaine. 
Procaine, synthesized in 1905, replaced cocaine due to its 
efficacy and longer lasting properties when combined with 
adrenaline [15]. Even more important, procaine did not 
possess the addictive property of cocaine. Rarely used these days 
as a local anesthetic, mostly secluded to ENT [ear, nose, and 
throat] procedures, the story of the cocaine  illustrates how a 
gateway drug laid the foundation for local anesthetic 
techniques and a search for improved agents. 
Lidocaine: In 1929 two chemists; Hans von Euler [1873- 
1964] and Sir Arthur Harden [1865-1940] were awarded the 
Nobel Prize for their work on fermentation. Von Euler then 
focused his efforts on developing barley strains that were 
resistant to loss of agricultural output to insects. He isolated 
a new pesticide called gramin. Von Euler and Holger Erdtman 
attempted to synthesize gramin but ended up synthesizing the 
incorrect isomer isogramin. When placed on the tongue, iso-
gramin resulted in a temporarily loss of sensation. 
   In von Euler’s laboratory in 1935, Holger Erdtman [1902- 1989] 
and Nils Lӧfgren [1913-1967] synthesized , different anilides with 
tongue numbing properties and published their results in 
1937[16]. Although none of the agents appeared to be superior to 
procaine, Lӧfgren continued to work on these compounds until 
1942 when his student Bengt Lundqvist [1922- 1953] convinced 
him that these drugs ought to be tested by injection rather than 
producing numbness of the tongue. After conducting a series of 
clinical experiments, they found that compound LL30 showed 
great promise as a local anesthetic [17].
Compound LL30 was tested on mice at the Karolinska 
Institute [Stockholm, Sweden]and found to have greater efficacy, 
longer duration of action and a less toxic profile than procaine. 
On July 15, 1943 Lӧfgren and Lundqvist applied for and 
obtained a 
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patent to protect their intellectual property rights. They licensed 
the product for a two-week trial and were disappointed when the 
medical and pharmaceutical community showed little interest 
in their drug. After considering several offers, they 
transferred ownership of the patent to Astra Pharmaceuticals 
[Sweden] on November 22, 1943 for 15,000 Swedish Crowns 
and 4% of all sales for 17 years. Rebranded and tested, Astra 
marketed the drug in early 1948 as Xylocaine.
Lӧfgren finished his doctorate in 1948 and published his 
thesis, “Studies on local anesthetics: Xylocaine: a new synthetic 
drug” [18]. He stayed on as a professor of organic chemistry at 
the University of Stockholm where he was precluded from 
winning research grants as a result of his financial success with 
compound LL30. Lundqvist sustained a skull fracture after a fall 
down a flight of stairs. He died from cerebral hemorrhage at the 
age of 30.
Chloroprocaine: When chloroprocaine was introduced to 
the market in 1952, lidocaine had already been used for epidural 
anesthesia as the first amino-amide anesthetic. Lidocaine was 
less likely to produce allergic reactions than the amino ester-
anesthetics [19]. In comparison to chloroprocaine, lidocaine 
provided a longer duration of action and was cleared less quickly 
from the body. Chemically similar to procaine, 2-Chloroprocaine 
became popular because of its rapid onset of action and 
metabolism by plasma esterases. It had virtually no effect on 
maternal-fetal physiology and was used extensively for pain relief 
during labor and delivery [20].
Numerous reports in the 1980s describing long term and 
even permanent neurological deficits due to local anesthetic 
agents sent a shockwave through the practice of regional 
analgesia [21]. Half a dozen cases reported prolonged 
transient neurological sequelae [TNS] and suggested that the 
cause might be accidental intrathecal infiltration during epidural 
catheter placement [22]. Reports of more cases involving 
accidental intrathecal injection with resulting 
permanent neurological sequelae, in some cases causing 
sexual dysfunction [23], forced the manufacturer to find ways to 
deal with these issues by altering the composition of the 
preservatives used in the manufacturing process. In 1987, 
Astra removed preservatives and marketed a UV light 
protected vial. Nonetheless, fear of causing potentially 
permanent neurologic complications lead the Food and Drug 
Administration [FDA] to prohibit the use of preservative 
containing chloroprocaine for lumbar and caudal epidural 
blocks.
Several hypotheses were put forward to explain these 
adverse effects. The high dose and volume of the local anesthetic 
were blamed initially. However, hundreds of deliberate spinal 
injections with the same doses had not produced adverse 
results [24]. Several of the early reports involved medications 
without preservatives, nonetheless, other studies suggested that 
preservatives such as methylparaben, ethylene diamine 
tetra acetate [EDTA], and sodium bisulfite were to blame [25]. 
It was known that these additives significantly prolonged the 
shelf life of the drug and inhibited bacterial growth. Studies 
on animal models and in-vitro neuronal stem cells showed 
proliferative and architectural changes when exposed to 2-
chloroprocaine with and without sodium bisulfite [26]. 
A study in animals by Taniguchi showed that intrathecal 
injection of sodium bisulfite caused less neurological 
dysfunction compared to chloroprocaine alone,  bringing into 
play more confusion about the identity of thecausative agent; 
was it the local anesthetic or the preservative? [27]. Despite 
this study, FDA regulations restrict Astra, the current 
manufacturer of chloroprocaine [Nesacaine-MPF] to market 
the drug without bisulfite. In Europe, epidural administration of 
chloroprocaine with preservatives is permitted and 
surveillance studies have not revealed evidence of neurological 
deficit. Thirty years later, there is a lack of clear evidence 
pointing to any single  mechanism responsible for neurotoxicity 
associated with the use of epidural chloroprocaine.
Bupivacaine and its toxicity: Numerous new amino amide 
local anesthetics were synthesized between 1898 and 1972 
including nirvaquine, procaine, chloroprocaine, cinchocaine, 
lidocaine, mepivacaine, prilocaine, efocaine, articaine, etidocaine, 
and bupivacaine [28]. Attempts were made to decrease toxicity, 
control onset and duration of action, and decrease the likelihood 
of drug dependence. 
It had already been established that the central nervous 
system was more susceptible to local anesthetics when compared 
to the cardiovascular system [29]. One pivotal case by Prentiss 
illustrated the danger of etidocaine during caudal anesthesia; 
causing convulsions and cardiac arrest in a health young male 
[30]. More examples of the toxic effects of local anesthetics 
emerged as Albright added five other case reports linked to 
lipid-soluble anesthetics and the dangerous effects on the 
cardiovascular system and the central nervous system [31]. As 
is the case with most established practices, resistance erupted 
against such causative claims. 
Bupivacaine, synthesized in 1957, is of special interest 
because of its long duration of action and history of 
clinical application. Several case reports highlighted the 
potential toxicity of 0.75% bupivacaine. This resulted in much 
investigative work to understand mechanisms  of its toxicity. 
In theory, the toxicity was thought to be related to the cardiac 
sodium channels [32]. The anesthetic was further 
characterized as “fast-in, slow-out” due to its prolonged 
blockade and a potent depressant of the maximum 
upstroke velocity of cardiac muscle action potential. 
Awareness of this unique behavior of bupivacaine led to the 
design of enantiomers, such as levo-bupivacaine and 
ropivacaine, each having their own physiological properties. 
These drugs, even in their present state, were still incredibly 
valuable to multimodal pain techniques and their use was 
“rescued” by an astute observation on a patient with carnitine-
deficiency. It was Weinberg who showed that the accumulation 
of fatty acids within the mitochondria enhanced the toxicity of 
bupivacaine [33]. Therefore, infusion of a lipid would emulsify the 
anesthetic and reduce its activity when toxicity was encountered. 
This was proven by his series of experiments on dogs and rats 
which showed the rescue effect of lipid emulsion therapy on the 
cardiotoxic effects of bupivacaine. 
Several years later, Rosenblatt showed its utility 
during cardiac arrest where electrical defibrillation was 
successful only after lipid infusion [34]. The mechanism is 
believed to be lipophyllic binding which isolates the drug in a 
'lipid sink”. 
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reducing the need for analgesics and hypnotics 
intraoperatively, and providing effective postoperative pain 
relief'.
Bier block [Intravenous Regional Anesthesia]: In August 
1908 Karl August Bier, Professor of Surgery in Berlin, revealed 
a new method of producing analgesia of a limb which he named 
‘vein anesthesia’ [47].
Bier first presented this new method of intravenous regional 
anesthesia [IVRA] at the 37th Congress of the German Surgical 
Society on 22 April 1908, only 10 years after other significant 
communication on spinal anesthesia [48]. The method consisted 
of occluding the circulation in a segment of the arm with two 
tourniquets and injecting a dilute local anesthetic through a 
venous cut-down in the isolated segment. Bier used procaine, the 
first safe injectable local anesthetic that had been synthesized by 
Einhorn in 1900 [15].
After initial enthusiasm, the technique fell into obscurity 
for >50 years. In 1963, Holmes reintroduced Bier block with the 
novel use of lidocaine [49]. 
Today, intravenous regional anesthesia of the upper limb 
remains popular because it is reliable, cost effective, safe, and 
simple to administer. 
Spinal and epidural anesthesia: The advent of spinal 
anesthesia cannot be fully accredited to the arrival of cocaine 
into the medical field. It served many purposes including 
ophthalmology, treatment of depression by Sigmund Freud [50], 
and even being added to Coca-Cola in 1886 [51]. The credit 
should go to the clinicians who first attempted to apply this 
drug to the spinal column. Procedures approximating the spinal 
column were regarded by the scientific and medical community 
as high risks with permanent paralysis being the result. However, 
these pioneers went ahead and tested their hypotheses, changing 
the field of anesthesiology and obstetrics.
Karl Gustav Bier [52], is credited with the first use of operative 
spinal anesthesia on the lower limbs although James Leonard 
Corning was the first to use cocaine in the spinal column in 1885 
[53], several years earlier than Bier [48]. A native of Stamford, 
CT, his family fled to Germany when he was a young boy. The 
influence of German and French physicians influenced Corning’s 
curiosity. Upon returning to the United States, he began his 
practice of Neurology in New York City, attending the 
Roosevelt Hospital. Corning had been in the surgical 
auditorium in 1884 when William Halstead and Richard Hall 
successfully demonstrated one of their peripheral nerve blocks 
[54]. A year later he first demonstrated spinal anesthesia by 
injecting 2 ml of 3% cocaine into the T11/T12 interspinous 
space in a gentleman suffering with “spinal weakness” and 
“seminal incontinence”. Minutes later the patient experienced 
impaired sensitivity in the legs, genitalia and lumbar region as 
well as post-dural puncture headache. The theory 
published by him stated that the mechanism of anesthesia 
was through the infusion of cocaine into the tissues 
surrounding the spinal column and by diffusion into the venae 
spinosae. Because his procedure did not describe fully 
penetrating the dura, he was not credited with being 
responsible for the first spinal block. Bier’s block did this in 
1899, entering the spinal column fully and injecting less of the 
cocaine solution to provide the anesthetic effects. He never 
applied his findings in the operating room, but 
Understanding the history behind the creation of these 
drugs allow a better appreciation in our daily practice.
 The Brachial Plexus: Halstead applied the theory of local 
anesthesia to peripheral nerves for surgery of the upper extremity, 
defending its use in the scientific community and encouraging 
others to discover its possibilities. A pupil of Halstead, Harvey 
Cushing, published a report concerning its efficacy with regard to 
avoiding complications of shock, comparing two surgeries on 
the shoulder, one without cocainization and the other with 
cocaine applied proximal to the division of nerve trunks [36].
The first percutaneous supraclavicular block was performed 
in 1911 by German surgeon Diedrich Kulenkampff [1880–
1967] [37]. Later, Georg Hirschel [1875–1963] described a 
percutaneous approach to the brachial plexus from the axilla 
[38]. Livingston compiled a review of the achievements of the 
time in 1927, stating, ‘On the basis of strict comparison, it 
cannot be said that the untoward effects from brachial plexus 
block are of more severity than those of inhalation narcosis. 
Furthermore, even in the experimental era, complications 
and disagreeable by-effects occurred with only a small 
percentage of patients, while the average patient receives the 
brachial plexus anesthesia without unfavorable symptoms' [39]. 
Thus he opened the door for regional anesthesia as a less 
harmful technique when compared with general anesthesia.
In 1928, Kulenkampff and Persky published a report about  
a thousand blocks without apparent major complications. 
The technique applied to the patient was described in that 
they would be in the sitting position or in the supine position 
with a pillow behind the shoulders. The needle was inserted 
above the midpoint of the clavicle where the pulse of the 
subclavian artery could be felt and it was directed medially 
toward the second or third thoracic spinous process [40]. By 
the late 1940s, clinical experience with brachial plexus block 
in both peacetime and wartime surgery was extensive, and 
new approaches to this technique began to emerge [41].
In 1946, F. Paul Ansbro was the first to describe a continuous 
brachial plexus block technique. This was done by a needle being 
secured in the supraclavicular fossa with tubing connected to 
a syringe through which incremental doses of local anesthetic 
could be injected [42]. The subclavian perivascular block was 
first described by Winnie and Collins in 1964 [43]. This approach 
became popular due to its lower risk of pneumothorax compared 
to the traditional Kulenkampff approach.
The infraclavicular approach was first developed by Raj 
in 1973 [44]. In 1977, Selander described a technique for 
continuous brachial plexus block using an intravenous catheter 
secured in the axilla [45]. The development of a more practical 
and portable nerve stimulator [NS] in 1962, led to increased 
use among practitioners. Reports questioning the safety of 
the paresthesia technique such as those by Selander in 1979 
encouraged clinicians to explore other approaches during the 
last decade of the 20th century. In 1989, another modality was 
introduced into clinical practice. Ting and Sivagnanatnam 
utilized ultrasound to confirm needle placement and observe 
local anesthetic spread during axillary nerve blocks [46]. 
'Today, upper extremity plexus blocks have an obvious 
place as a sole anesthetic technique or as a powerful 
complement to general anesthesia, 
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in newborns with biliary atresia and subsequently found that 
by using continuous infusions via caudal catheter, the need for 
postoperative ventilation in babies with oesophageal atresia 
and other surgical conditions was reduced. His work 
demonstrated that epidural analgesia can be provided for 
neonates undergoing major surgery with a low risk of 
complication [63]. Further advantages include the reduced 
need for muscle relaxants, opioids and postoperative 
ventilatory support.
Spinal and other local anesthetic techniques in children had 
ups and downs in popularity likely related to improvements in 
general anesthesia.
Ultrasound Guidance: A technology originally used to detect 
submarines during warfare, ultrasound found initial medical use 
in fetal monitoring and identification of gallstones, but it would 
take several decades before it was adopted to identify nerves. 
In 1978 La Grange developed a unique approach of 
delivering local anesthesia to the brachial plexus using Doppler 
ultrasonography [58].
This type of ultrasonography only provided 
unidimensional images and they reported no neurological 
sequelae or pneumothorax. It did not become popular due 
to the prohibitive cost of this technology. In 1989 Ting 
described ultrasonographic visualization of local anesthetic 
spread during brachial plexus block. Instead of Doppler, they 
use a B-mode ultrasound device that provided two-
dimensional visualization. Their conclusions emphasized 
improved visualization of the brachial plexus but did not 
comment on improved efficacy and safety.
In 1994, Kapral [64], reported a significant decrease in the 
amount of anesthetic needed to produce clinical analgesia using 
ultrasound guidance during brachial plexus block. Moreover, 
the technique was associated with fewer complications, while 
patients reported less discomfort. The stage was set for a 
revolution in techniques used to identify neural structures that 
could be blocked with local anesthetic agents. Improvements in 
anesthetic techniques can bring about major changes in surgical 
approaches. Ultrasound guided regional anesthetics have enabled 
patients to emerge from minimally invasive day-surgery with 
almost no pain or side effects. 
Regional vs General Anesthesia: any improvement 
in outcomes?: As in all fields of medicine, there has been an 
explosive growth in clinical research related to regional 
anesthesia. In 1987, Yeager [59] and colleagues showed a 
dramatically reduced mortality in high-risk patients who 
received regional anesthesia. In 2000, Rodgers and colleagues 
published an extensive meta-analysis showing a reduction 
in postoperative mortality and morbidity with neuraxial 
anesthesia with the subsequent recommendation of more 
widespread use of this technique [60].
Spinal anesthesia is the preferred anesthetic method for sub-
umbilical surgery, particularly in elderly patients and parturients. 
Parker and colleagues [61], investigated in a Cochrane meta-
analysis 22 clinical trials involving 2567 patients where 
neuraxial [mainly spinal] anesthesia was compared with 
general anesthesia for hip fracture surgery. The authors found 
a reduced risk for postoperative deep venous thrombosis 
[30% compared with 47%] and acute postoperative confusion 
[9.4% compared 
he may have used this technique to relieve forms of paresthesia 
in his own patients. 
Despite the utility of spinal anesthesia, the preference of 
spinal anesthesia for nerve blockade and lower extremity surgery 
was secondary to general anesthesia because of the feared 
neurologic sequelae. 
One case report detailed paraplegia with two previously 
healthy middle aged males [55,56]. 
In 1956, a study from the Hospital of the University of 
Pennsylvania by Dripps and Vandam showed that a long term 
follow up of over 10,000 patients who received spinal anesthesia 
resulted in no long term neurologic sequelae [57].These findings 
improved the public image of spinal blocks and their use in the 
operating room and in pain clinics [58,59]. 
Caudal blocks and epidurals came into use in children much 
later. In the early years these blocks were performed by surgeons, 
but as other doctors began to give anesthetics the specialty 
of anesthesia evolved, and these practitioners gradually took 
over this role. On August 16, 1898, August Bier tried to induce 
spinal anesthesia with cocaine. All of his six patients, including 
two children – the first to have spinals – had postoperative 
vomiting and headache, and Bier felt that the technique had little 
advantage over general anesthesia. In 1909–1910,H. Tyrell Gray, 
superintendent at the Hospital for Sick Children at Great 
Ormond Street, London, published three detailed papers each 
based on more than 100 cases of spinal anesthesia in children. 
They occupied 14 ½ pages in the Lancet [60].Gray’s patients 
were not anesthetized but were comforted by a nurse who knew 
them. Some were even allowed to have cake! Six retched and 21 
vomited during the anesthetic. The incidence of vomiting 
postoperatively was very low, only 2%. In three patients, spinal 
anesthesia failed, and general anesthesia was instituted. Gray 
concluded that the benefits to the patient were as follows: 
absolute anesthesia, no surgical shock, the analgesia was 
localized to the area of the block, and postoperative vomiting 
was minimal. The advantages for the surgeon were as 
follows: good operating conditions, easy access to the 
abdomen, the bowel was constricted, surgery could be 
completed quickly, and the anesthetic could be administered 
by the surgeon. Postoperatively, there was less pain, and 
feeding could be started sooner. These papers illustrate how 
much was known about spinal anesthesia in children, more 
than 100 years ago.
Caudal blocks now play a major role in pediatric anesthesia, 
but they were first reported for cystoscopies in children by 
Meredith Campbell when she presented a paper to the American 
Society of Regional Anesthesia in 1933 [61]. By 1950, Harry 
Curwen in Durban, South Africa, was using caudal blocks in 
neonates, he recognized the potential advantages, especially 
for the occasional pediatric anesthetists or doctors working in 
the rural areas [61]. Schulte Steinberg, who had trained 
with Philip Bromage in Montreal, working in the county hospital 
in Starnberg [Germany] used caudal anesthesia and 
undertook studies on the dermatomal levels reached in 
children, with different volumes of local anesthetic with 
added X-ray contrast. Schulte Steinberg went on a sabbatical in 
Durban, where caudal anesthesia was used commonly. He 
studied caudal catheters in piglets and human cadavers and 
found it was possible to thread them  easily to the thorax in small 
children [62]. Bosenberg then applied the method clinically 
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with 19.2%] in patients treated with neuraxial [mainly spinal] 
anesthesia compared with general anesthesia. There was no 
evidence for reduced perioperative mortality. Peripheral nerve 
blocks and local anesthesia have very few cardiovascular 
or pulmonary side-effects. Complications do occur, and 
peripheral nerve block must be performed with adequate 
safety precautions by anesthetists with appropriate 
experience. In experienced hands, it seems likely that 
peripheral nerve block would be safer than general 
anesthesia due primarily to the avoidance of airway 
management. However, evidence to prove this assumption will 
never be available due to the low numbers of severe anesthesia-
related complications. At the same time opioid consumption can 
be decreased or even avoided, in consequence, opioid-related 
side-effects can be reduced when perineural block is performed. 
Whether regional anesthesia influences outcome after surgery 
is a controversial topic, in skilled hands, various regional 
anesthetic techniques are powerful tools providing almost 
perfect perioperative pain therapy. Using an optimal 
balance between appropriate techniques, application of 
advanced equipment, and optimal doses of drugs, regional 
anesthesia plays an important role in perioperative medicine.
Conclusions
Regional anesthesia has a fascinating history, with events 
following the introduction of general anesthesia by a half-
century. As with general anesthesia, techniques and drugs 
have evolved over time, and currently many patients receive 
concurrent care under both techniques. During the late 
19th and early 20th century regional anesthesia was the 
preferred technique because of complications associated 
with general anesthesia, and a shortage of anesthesia 
providers. Ensuing decades showed the use of regional 
anesthetics decreasing as general anesthesia became safer. 
However, recent advances in techniques, drugs and 
applications have led to a resurgence in the use of regional 
anesthesia. We believe historical aspects of regional 
anesthesia can and should be taught as part of the 
educational curriculum.
References 
1. Sim P. The heritage of anesthesia. Park Ridge, Illinois: Wood Library-
Museum of Anesthesiology; 2012.
2. Eger EI, Saidman LJ, Westhorpe RN. The wondrous story of anesthesi.New 
York: Springer. 2014.
3. Karch S. A Brief History of Cocaine: From Inca Monarchs to Cali Cartels: 500 
years of Cocaine Dealing. Bocan Raton: CRC Press; 2006.
4. Karch SB. A history of cocaine: The mystery of coca java and the kew plant. 
J R Soc Med. 2003 ; 96[11]:568–569.
5. Willstatter RM, Stoll A. From my life: The memoirs of Richard Willstatter. New 
York: Benjamin; 1965.
6. Willstatter R, Wolfes D, Mader H. Synthese des naturlichen cocains. Justus
Liebigs Ann Chem. 1923;434:111-139.
7. Markel H. An anatomy of addiction: Sigmund Freud, William Halsted, and the 
miracle drug cocaine. New York: Pantheon Books; 2011.
8. Freud S. Ueber coca. Zentralblatt Ges Ther. 1884;2:289-314.
9. Koller C. Preliminary report on local anesthesia of the eye [translated report of 
the original presentation at the 1884 meeting of the German Ophthalmological 
Society, at Heidelberg]. Arch Ophthalmol.1934;12[4]:473-474.
10. von Anrep NB. Ueber die physiologischen wirkungen des cocains. Pfluger‘s 
Arch Ges Physiol. 1880;21[1]:38-77.
11. Aschenbrandt T. Die physiologische wirkung und die bedeutung des
cocain. Muriat auf den menschlichen organismus. Dtsch Med Wochenschr. 
1883;50:730-732.
12. Raymond EH. Hydrochlorate of cocaine as a local anesthetic in dental
surgery. Dental Cosmos. 1885;27:207-226.
13. Halsted WS. Practical comments on the use and abuse of cocaine;
suggested by its invariably successful employment in more than a thousand 
minor surgical operations. New York Medical Journal. 1885;42:294-295.
14. Redman M. Cocaine: What is the Crack? A Brief History of the Use of
Cocaine as an Anesthetic. Anesthesiology and Pain Medicine. 2011;1[2]:
95-97.
15. Einhorn A. Ueber neue arzneimittel. Liebig‘s Ann Chemie. 1900;311:26-77.
16. Erdtman H, Lofgren N. Uber eine neue gruppe von lokalanasthetisch
wirksamen verbingdungen. Svensk Kemisk Tidskrift. 1937;49:163-174.
17. Lofgren N, Lundqvist B. Studies on local anaesthetics II. Svensk Kemisk
Tidskrift. 1946;58:206-217.
18. Lofgren N. Studies on local anesthetics. Xylocaine, a new synthetic drug.
Stockholm: Chemistry, Stockholms Hogskola; 1948.
19. Eggleston ST, Lush LW. Understanding allergic reactions to local anesthetics. 
Annals of Pharmacotherapy. 1996;30[7-8]:851-857.
20. Bonica JJ. Obstetric analgesia and anesthesia: A manual for medical
students, physicians in training, midwives, nurses and other health
personnel. Amsterdam: World Federation of Societies of Anesthesiologists; 
1980.
21. Reisner LS HB, Plumer MH. Persistent neurologic deficit and adhesive 
arachnoiditis following intrathecal 2-chloroprocaine injection. Anesthesia 
Analgesia.1980;59[60] :452-454.
22. Ravindran RS BV, Tasch MD, Gupta CD, Luerssen TG. Prolonged neural
blockade following regional anesthesia with 2-chloroprocaine. Anesthesia 
Analgesia.1980; 59[6]:447-451.
23. Moore D, Spierdik, J., van Kleef, JD., Coleman, RL., Love, GF.
Chloroprocaine neurotoxicity: four additional cases. Anesthesia Analgesia. 
1982; 61[2]:155-159.
24. Gissen A. The Chloroprocaine Controversy: I. A Hypothesis to Explain the
Neural Complications of Chloroprocaine. Regional Anesthesia. 1984;124-
134.
25. Gissen A. The Chloroprocaine Controversy: II. Is Chloroprocaine Neurotoxic? 
Regional Anesthesia. 1984;9:135-145.
26. Baker M. Cocaine or Sulfite Toxicity? Anesthesiology. 2004:1247.
27. Taniguchi M. Sodium Bisulfite: Scapegoat for Chloroprocaine Neurotoxicity? 
Anesthesiology. 2004;85-91.
28. Ruetsch Y, Boni, T, Borgeat, A. From cocaine to ropivacaine: the history of
local anesthetic drugs. Curr Top Med Chem. 2001;175-182.
29. Di Gregorio G, Neal JM, Rosenquist RW, Weinberg GL. Clinical presentation 
of local anesthetic systemic toxicity: A review of published cases, 1979 to
2009. Reg Anesth Pain Med. 2010;35:181-187.
30. Prentiss JE. Cardiac arrest following caudal anesthesia. Anesthesiology. 
1979;50:51-53.
31. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or
bupivacaine. Anesthesiology. 1979;51:285-287.
32. Clarkson CH, LM. Mechanism for bupivacaine depression of cardiac
conduction: fast block of sodium channels during the action potential with
slow recovery from block during diastole. Anesthesiology. 1985;396-405.
33. Weinberg G, Laurito, CE. Geldner, P. Pygon, BH. Burton, BK. Malignant
ventricular dysrhythmias in a patient with isovaleric acidemia receiving
general and local anesthesia for suction lipectomy. Journal of Clinical
Anesthesiology. 1997;668-670.
34. Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful 
use of a 20% lipid emulsion to resuscitate a patient after a presumed
bupivacaine-related cardiac arrest. Anesthesiology. 2006;105:217-218.
35. Litz RJ, Popp M, Stehr SN, Koch T. Successful resuscitation of a patient with 
ropivacaine-induced asystole after axillary plexus block using lipid infusion.
Anaesthesia. 2006;61:800-801.
Citation: Gustavo Angaramo, James Savage, David Arcella,  Manisha S. Desai (2019). A Comprehensive Curriculum of The History of Regional Anesthesia.
Page 7 of 7
www.scientonline.org J Clin Anesth Pain MedVolume 3 • Issue 1 • 026
36. Cushing H. On the Avoidance of Shock in Major Amputations by Cocainization 
of Large Nerve-Trunks Preliminary to their Division. With Observations on
Blood-Pressure Changes in Surgical Cases. Annals of Surgery. 1902;321-
345.
37. Kulenkampff D. Zur anästhesierung des plexus brachialis [in German] [On 
anesthesia of the brachial plexus]. Zentralblatt fur Chirurgie. 1911;38:1337-
1340.
38. Hirschel G. Die anasthesierung des plexus brachialis fuer die operationen
an der oberen extremitat [in German] [Anesthesia of the brachial plexus for
operations on the upper extremity]. Munchener Medizinische Wochenschrift. 
1911;58:1555-1556.
39. Livingston E. Brachial Plexus Block: Its Clinical Application. JAMA. 
1927:1465-1468.
40. Kulenkampff D, Persky MA. Brachial plexus anaesthesia: Its indications, 
technique, and dangers. Annals of Surgery. 1928;87:883-891.
41. de Pablo JS, Diez-Mallo J. Experience with three thousand cases of brachial 
plexus block: Its dangers: Report of a fatal case. Ann Surg. 1948;128:956-
964.
42. Ansbro FP. A method of continuous brachial plexus block. American Journal 
of Surgery. 1946;71:716-722.
43. Winnie AP, Collins VJ. The subclavian perivascular technique of brachial
plexus anesthesia. Anesthesiology. 1964;25:353-363.
44. Raj PP, Montgomery SJ, Nettles D, Jenkins MT. Infraclavicular brachial
plexus block. Anesth Analg. 1973;52:897-904.
45. Selander D. Catheter technique in axillary plexus block: Presentation of a
new method. Acta Anaesthesiol Scand. 1977;21:324-329.
46. Ting PL, Sivagnanaratnam AM. Ultrasonographic study of the spread of local 
anaesthetic during axillary brachial plexus block. Br J Anaesth. 1989;63:326-
329.
47. Bier A. Ueber einen neuen Weg Localanasthesie an den Gliedmassen zu
erzeugen [On a new technique to induce local anesthesia in extremities]. 
Arch Klin Chir 1908;86:1007-1016.
48. Bier A. Versuche uber Cocainisirung des Ruckenmarkes [Experiments on
the cocainization of the spinal cord]. Dtsch Z Chir. 1899;51:361-369.
49. Holmes C. The history and development of intravenous regional anesthesia. 
. Acta Anaesthesiologica Scandinavica. 1969:11-18.
50. Freud S. Cocaine papers. New York: Stonehill; 1975.
51. Boville Luca de Tena B. The cocaine war: In context: Drugs and politics. New 
York: Algora Publishing; 2004.
52. Hinnerk FWW. The centennial of spinal anesthesia. Anesthesiology. 
1998;89:500-506.
53. Corning J. Spinal anaesthesia and local medication of the cord. NY Med J. 
1885;42:483-485.
54. Looseley A. Corning and cocaine: the advent. 2001.
55. Cope RW. The Woolley and Roe case: Woolley and Roe versus Ministry of
Health and Others. Anaesthesia. 1954;9:249-270.
56. Maltby JR, Hutter CDD, Clayton KC. The Woolley and Roe case. Br J
Anaesth. 2000;84:121-126.
57. Vandam LD, Dripps RD. Long-term follow-up of patients who received
10,098 spinal anesthetics: Syndrome of decreased intracranial pressure
[headache and ocular and auditory difficulties]. Journal of the American
Medical Association. 1956;161:586-591.
58. La Grange P, Foster P, Pretorius L. Application of the Doppler ultrasound
blood flow detector in supraclavicular brachial plexus block. Br j Anaesth. 
1978;50:965-967.
59. Yaeger MP, Glass DD, Neff RK, Brinck-Johnsen T. Epidural anesthesia and 
analgesia in high risk surgical patients. Anesthesiology. 1987;66:729-736.
60. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality
and morbidity with epidural or spinal anaesthesia: results from overview of
randomised trials. British Medical Journal. 2000;321:1493-1493.
61. Parker MJ, Handoll HH, Griffiths R. Anaesthesia for hip fracture surgery in 
adults Surgery in adults. Cochrane Database Syst Rev. 2001;4:CD000521.
Copyright: © 2019 Manisha Desai S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
